Literature DB >> 12679399

PET imaging of prostate cancer with 11C-acetate.

Antonia Dimitrakopoulou-Strauss1, Ludwig G Strauss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12679399

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  19 in total

1.  Is 11C-choline the most appropriate tracer for prostate cancer? For.

Authors:  Ferruccio Fazio; Maria Picchio; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-02       Impact factor: 9.236

2.  Malignant lipogenesis defined by 11C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomy.

Authors:  Naresh Regula; Michael Häggman; Silvia Johansson; Jens Sörensen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-08       Impact factor: 9.236

3.  Exploiting tumor metabolism: challenges for clinical translation.

Authors:  Matthew G Vander Heiden
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

4.  Dynamin-dependent amino acid endocytosis activates mechanistic target of rapamycin complex 1 (mTORC1).

Authors:  Shusaku Shibutani; Hana Okazaki; Hiroyuki Iwata
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

5.  (11)C-acetate PET in the early evaluation of prostate cancer recurrence.

Authors:  Susanne Albrecht; Franz Buchegger; Dmitri Soloviev; Habib Zaidi; Hansjoerg Vees; Haleem G Khan; Alain Keller; Angelika Bischof Delaloye; Osman Ratib; Raymond Miralbell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-11       Impact factor: 9.236

Review 6.  Targeting cancer metabolism: a therapeutic window opens.

Authors:  Matthew G Vander Heiden
Journal:  Nat Rev Drug Discov       Date:  2011-08-31       Impact factor: 84.694

Review 7.  Functional imaging for prostate cancer: therapeutic implications.

Authors:  Carina Mari Aparici; Youngho Seo
Journal:  Semin Nucl Med       Date:  2012-09       Impact factor: 4.446

8.  2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer.

Authors:  Nagavarakishore Pillarsetty; Blesida Punzalan; Steven M Larson
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

9.  11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.

Authors:  Y Yamamoto; Y Nishiyama; N Kimura; R Kameyama; N Kawai; T Hatakeyama; M Kaji; M Ohkawa
Journal:  Mol Imaging Biol       Date:  2008-06-10       Impact factor: 3.488

Review 10.  Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.

Authors:  Hossein Jadvar
Journal:  Nat Rev Urol       Date:  2009-05-12       Impact factor: 14.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.